Back
Aquestive Therapeutics Vs. Cormedix Industry Stock Comparison
Sell
50
AQST
Aquestive Therapeutics
Last Price:
4.95
Seasonality Move:
-18.65%
Sell
33
CRMD
Cormedix
Last Price:
9.95
Seasonality Move:
47.98%
Sell
50
Aquestive Therapeutics (AQST)
is a Sell
Is Aquestive Therapeutics a Buy, Sell or Hold?
- The current Aquestive Therapeutics [AQST] share price is $4.88. The Score for AQST is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- AQST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Cormedix (CRMD)
is a Sell
Is Cormedix a Buy, Sell or Hold?
- The current Cormedix [CRMD] share price is $9.78. The Score for CRMD is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- CRMD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AQST Stock Price Chart
What is Aquestive Therapeutics's stock price today?
-
The Aquestive Therapeutics share price today is $4.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AQST is experiencing slight selling pressure.
CRMD Stock Price Chart
AQST Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 49.71 | Sell |
| Chaikin Money Flow: | -252301 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.68 - 5.44) | Sell |
| Bollinger Bands (100): | (3.59 - 5.19) | Buy |
CRMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 42.8 | Sell |
| Chaikin Money Flow: | 86703 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.92 - 12.16) | Sell |
| Bollinger Bands (100): | (4.75 - 10.31) | Buy |
AQST Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.67 | Buy |
| 20-day SMA: | 4.95 | Sell |
| 50-day SMA: | 4.98 | Sell |
| 200-day SMA: | 3.96 | Buy |
| 8-day EMA: | 4.75 | Buy |
| 20-day EMA: | 4.86 | Buy |
| 50-day EMA: | 4.82 | Buy |
| 200-day EMA: | 3.93 | Buy |
CRMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.38 | Sell |
| 20-day SMA: | 10.58 | Sell |
| 50-day SMA: | 9.97 | Sell |
| 200-day SMA: | 6.04 | Buy |
| 8-day EMA: | 10.32 | Sell |
| 20-day EMA: | 10.57 | Sell |
| 50-day EMA: | 9.76 | Buy |
| 200-day EMA: | 6.81 | Buy |
Aquestive Therapeutics Earnings Growth & AQST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.12 per share.
Cormedix Earnings Growth & CRMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.98 per share.
Aquestive Therapeutics Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cormedix Technical Analysis
| Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||